Compare SRTA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRTA | MLAB |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | 601 | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.1M | 461.9M |
| IPO Year | N/A | 1995 |
| Metric | SRTA | MLAB |
|---|---|---|
| Price | $4.48 | $99.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $7.81 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 649.7K | 82.3K |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | $39.27 | $6.07 |
| Revenue Next Year | $9.09 | $5.41 |
| P/E Ratio | ★ $9.88 | $51.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.85 | $59.63 |
| 52 Week High | $6.02 | $128.55 |
| Indicator | SRTA | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.91 | 67.73 |
| Support Level | $4.23 | $69.02 |
| Resistance Level | $4.69 | $103.73 |
| Average True Range (ATR) | 0.16 | 3.76 |
| MACD | 0.05 | 1.26 |
| Stochastic Oscillator | 89.57 | 86.81 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.